MSD Animal Health, a division of multinational pharmaceutical company Merck & Co, Inc., Kenilworth, NJ, USA, today announced the launch of the PORCILIS® Ery + Parvo + Lepto vaccine, the new triple vaccine with broad protection against the three most significant, today, May 31 diseases of the reproductive system of pigs.

Erysipelas, porcine parvovirus and leptospirosis affect pig reproductive health. The vaccine, the latest innovation in the pig vaccination portfolio, provides up to 12 months of proven immunity for sows and pigs and provides the broadest protection against leptospirosis.

The new easy-to-use vaccine PORCILIS® Ery + Parvo + Lepto allows farmers and manufacturers to effectively administer three vaccines in one injection at a time and can be used for mass vaccination during pregnancy. It can be used as a prophylactic alternative against infections of leptospirosis and erysipelas, very contagious diseases, often affecting pigs.

Ruud Segers, Head of Global Animal Health Research, said: “The PORCILIS® Ery + Parvo + Lepto vaccine offers the broadest range of protection against leptospirosis, offering proven protection against nine different serotypes.

The duration of immunity after vaccination for most leptospira is up to 12 months. The presence of both adapted and non-adapted pig-specific serovars Leptospira in one vaccine builds on our heritage in developing complex vaccine combinations and underlines our continued commitment to the Science of Healthy Animals.

Vaccines play an important role in protecting animal health. Timely and effective vaccination reduces the incidence and severity of the disease.